USAMRIID
USAMRIID Banner

About USAMRIID

Scientific Publications

Medical Library

Business Opportunities

Employment

Education & Training

Biological Safety

Unified Culture Collection

Special Pathogens Lab

Reference Materials

Related Links

Newsroom/Media

Contact Us

Search

iSALUTE External Link, Opens in New Window



USAMRIID logo
Monkeypox virus infection
Messenger RNA Technology Could Be Used to Develop Infectious Disease Therapeutics
Army scientists and industry partners were among the first to demonstrate that messenger RNA (mRNA)–the technology recently used in COVID-19 vaccines and others–could also be used to develop treatments for infectious diseases.
Sgt. Ibrahim Toure
Soldier finds success, citizenship in US Army
Austin, Texas – Sgt. Ibrahim Toure had planned and waited for years to make it to the United States, a place he thought of as offering greater freedom and possibilities.
Crimean-Congo Hemorrhagic Fever
Research Sheds Light on Crimean-Congo Hemorrhagic Fever Disease Process
Army scientists determined that the body's own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans.
Hantavirus STM Viral
Antibody Shows Promise for Developing Hantavirus Treatment
An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according to a study published online Mar. 16 in Science Translational Medicine.
Xiankun (Kevin) Zeng, Ph.D.
USAMRIID Scientist Wins AMSUS Research and Development Award
Xiankun (Kevin) Zeng, Ph.D., a molecular biologist and principal investigator at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), is the recipient of the 2021-2022 Research and Development Award presented by AMSUS, the Society of Federal Health Professionals.
Ebola virus (brown)
Study Reveals Ebola Virus Can Hide in Brain, Persist Even After Treatment
In a groundbreaking study published today, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease–even long after treatment with monoclonal antibodies.
Angiotensin Converting Enzyme
Scientists Develop First Lethal Hamster Model for COVID-19
Army scientists, in collaboration with Utah State University, have developed a lethal hamster model for SARS-CoV-2, the virus that causes COVID-19.
capsule slide
Experimental Treatment with Enzyme Protects Mice from Lethal Anthrax Infection
Scientists have demonstrated that modifying an enzyme produced by the bacterium that causes anthrax can protect mice from infection with the deadly disease.
Bootstrap Slider

— Mission —

To provide leading edge medical capabilities to deter and defend against current and emerging biological threat agents.

— Vision —

To advance medical biological defense to protect our military
and the nation.

Since 1969, USAMRIID has served as the Department of Defense's (DoD) lead laboratory for medical biological defense research.  While our core mission is to protect the warfighter from biological threats, we also investigate disease outbreaks and threats to public health.  Research conducted at USAMRIID leads to medical solutions—therapeutics, vaccines, diagnostics, and information—that benefit both military personnel and civilians. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.




Video  View USAMRIID - The Cornerstone of National Medical Biodefense
(8:22 Mins)